Platelet transfusion: Current challenges.
Fiche publication
Date publication
juillet 2018
Journal
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GACHET Christian
Tous les auteurs :
Humbrecht C, Kientz D, Gachet C
Lien Pubmed
Résumé
Since the late sixties, platelet concentrates are transfused to patients presenting with severe thrombocytopenia, platelet function defects, injuries, or undergoing surgery, to prevent the risk of bleeding or to treat actual hemorrhage. Current practices differ according to the country or even in different hospitals and teams. Although crucial advances have been made during the last decades, questions and debates still arise about the right doses to transfuse, the use of prophylactic or therapeutic strategies, the nature and quality of PC, the storage conditions, the monitoring of transfusion efficacy and the microbiological and immunological safety of platelet transfusion. Finally, new challenges are emerging with potential new platelet products, including cold stored or in vitro produced platelets. The most debated of these points are reviewed.
Mots clés
Bleeding, Blood product, Plaquettes, Platelets, Produit sanguin, Safety, Saignement, Sécurité, Transfusion
Référence
Transfus Clin Biol. 2018 Jul 20;: